Predicted protein targets (top 14)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TSHR | P16473 | 1/20 | 0.71 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.50 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.50 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.50 |
| ▸ | KLK7 | P49862 | 7/20 | 0.49 |
| ▸ | PAM | P19021 | 1/20 | 0.49 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.47 |
| ▸ | CES2 | O00748 | 1/20 | 0.45 |
| ▸ | CES1 | P23141 | 1/20 | 0.45 |
| ▸ | AKR1B1 | P15121 | 1/20 | 0.45 |
| ▸ | CYP19A1 | P11511 | 1/20 | 0.45 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.45 |
| ▸ | LMNA | P02545 | 1/20 | 0.45 |
| ▸ | FAAH | O00519 | 1/20 | 0.44 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL873430 | 0.83 | TSHR (1.00) | TSHRALDH1A1MAPK1L3MBTL1KLK7 | |
| SCHEMBL28389293 | 0.83 | TSHR (0.67) | TSHRALDH1A1MAPK1L3MBTL1KLK7 | |
| SCHEMBL11327414 | 0.83 | TSHR (0.67) | TSHRALDH1A1MAPK1L3MBTL1KLK7 | |
| SCHEMBL23611413 | 0.81 | TSHR (0.55) | TSHRALDH1A1MAPK1L3MBTL1PAM | |
| Hydrochloric Acid SCHEMBL27332250 | 0.81 | TSHR (0.96) | TSHRALDH1A1MAPK1L3MBTL1KLK7 | |
| SCHEMBL27120274 | 0.81 | TSHR (0.76) | TSHRALDH1A1MAPK1L3MBTL1KLK7 | |
| SCHEMBL28134676 | 0.81 | TSHR (0.76) | TSHRALDH1A1MAPK1L3MBTL1KLK7 | |
| SCHEMBL27883126 | 0.81 | TSHR (0.96) | TSHRALDH1A1MAPK1L3MBTL1KLK7 | |
| SCHEMBL8847851 | 0.81 | TSHR (0.65) | TSHRALDH1A1MAPK1L3MBTL1KLK7 | |
| SCHEMBL13333910 | 0.81 | TSHR (0.65) | TSHRALDH1A1MAPK1L3MBTL1KLK7 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 15 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-112778442-A | Olefin polymerization catalyst solid component, preparation method thereof, olefin polymerization catalyst and application | 中国石油化工股份有限公司 | 2021-05-11 | — | — | CN | claimed |
| CN-112759683-A | Olefin polymerization catalyst and application | 中国石油化工股份有限公司 | 2021-05-07 | — | — | CN | claimed |
| CN-116135892-B | Method for preparing bimodal polyethylene resin for pipe material and bimodal polyethylene resin thereof | 中国石油化工股份有限公司 | 2024-10-15 | — | — | CN | disclosed |
| CN-116135892-A | Method for preparing bimodal polyethylene resin for pipe material and bimodal polyethylene resin thereof | 中国石油化工股份有限公司 | 2023-05-19 | — | — | CN | disclosed |
| CN-111057169-B | Catalyst for olefin polymerization and preparation method and application thereof | 中国石油化工股份有限公司 | 2023-02-28 | — | — | CN | disclosed |
| CN-112778442-A | Olefin polymerization catalyst solid component, preparation method thereof, olefin polymerization catalyst and application | 中国石油化工股份有限公司 | 2021-05-11 | — | — | CN | disclosed |
| CN-112759683-A | Olefin polymerization catalyst and application | 中国石油化工股份有限公司 | 2021-05-07 | — | — | CN | disclosed |
| CN-111057168-A | Catalyst for olefin polymerization and preparation method and application thereof | 中国石油化工股份有限公司 | 2020-04-24 | — | — | CN | disclosed |
| CN-103772536-B | A kind of catalytic component for vinyl polymerization or combined polymerization and catalyst thereof | SINOPEC CORP. (CN) | 2016-05-25 | — | — | CN | disclosed |
| US-8946144-B2 | Phosphonated glycopeptide and lipoglycopeptide antibiotics and uses thereof for the prevention and treatment of bone and joint infections | THE MEDICINES COMPANY (US) | 2015-02-03 | — | — | US | disclosed |
| US-8901072-B2 | Glycopeptide and lipoglycopeptide antibiotics with improved solubility | THE MEDICINES COMPANY (US) | 2014-12-02 | — | — | US | disclosed |
| US-20120149632-A1 | GLYCOPEPTIDE AND LIPOGLYCOPEPTIDE ANTIBIOTICS WITH IMPROVED SOLUBILITY | THE MEDICINES COMPANY (US) | 2012-06-14 | — | — | US | disclosed |
| US-20100113333-A1 | PHOSPHONATED GLYCOPEPTIDE AND LIPOGLYCOPEPTIDE ANTIBIOTICS AND USES THEREOF FOR THE PREVENTION AND TREATMENT OF BONE AND JOINT INFECTIONS | TARGANTA THERAPEUTICS, INC. (CA) | 2010-05-06 | — | — | US | disclosed |
| US-5107034-A | Bromination of 4-hydroxyacetophenone, treating with methoxide to produce alpha-methoxy-4-hydroxyacetophenone, reduction | HOECHST CELANESE CORPORATION (US) | 1992-04-21 | — | — | US | disclosed |
| EP-0449602-A1 | Method for producing 4-(2'-methoxyethyl) phenol | HOECHST CELANESE CORPORATION (US) | 1991-10-02 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20100113333-A1 | PHOSPHONATED GLYCOPEPTIDE AND LIPOGLYCOPEPTIDE ANTIBIOTICS AND USES THEREOF FOR THE PREVENTION AND TREATMENT OF BONE AND JOINT INFECTIONS | PGLS, BPGM, PAG1 | TSHR 4348/4885ALDH1A1 4184/4885MAPK1 1463/4885 |
| US-20120149632-A1 | GLYCOPEPTIDE AND LIPOGLYCOPEPTIDE ANTIBIOTICS WITH IMPROVED SOLUBILITY | NGLY1, LGALS3BP, GYPA | TSHR 3204/4885ALDH1A1 4197/4885MAPK1 3513/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.